Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
topic_facet:"COVID-19"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22COVID-19%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22COVID-19%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22COVID-19%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (3.236)
1
Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations : A Randomized Controlled Trial to Reduce Hopelessness Through Enhanced Physical Activity in Adults With Ischemic Heart Disease
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19 : Multicenter, Randomized, Double Blind, Placebo Controlled Parallel Group Study Evaluating Efficacy, Reactogenicity and Safety of Recombinant Vaccine Ad5-nCoV Against Novel Coronavirus Infection in Adult Volunteers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Phase 1 Trial of ChAd68 and Ad5 Adenovirus COVID-19 Vaccines Delivered by Aerosol : Phase 1, Open Label Study to Evaluate the Safety and Immunogenicity of ChAd68 and AdHu5 Vector-based Trivalent COVID-19 Vaccines Delivered Via Inhaled Aerosol
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis : Phase 1 Clinical Trial of a Q GRFT Nasal Spray
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19) : CATCH-UP Vaccines: Extension of Community - Engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines : A Multi-Part, Phase 3, Randomized, Observer Blinded Study to Evaluate the Safety and Immunogenicity of Omicron Subvariant and Bivalent SARS-CoV-2 rS Vaccines in Adults Previously Vaccinated With Other COVID-19 Vaccines
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster : Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster Following Primary Vaccination of Either Inactivated or mRNA or Viral Vector COVID-19 Vaccines
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102) : A Randomized, Parallel Controlled, Double-blind, Single-center Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell)(WSK-V102) in People Aged 18 Years or Older
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) : A Single-center, Randomized, Double-blind, Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of Booster Vaccination of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) in Healthy People Aged 18 Years and Older
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination : A Multicenter, Randomized, Double-Blind, Controlled, Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination to Evaluate Efficacy, Safety and Immunogenicity in Population Aged 18 Years Old and Above
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[324]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: COVID-19
Medienart
3.236
Aufsätze
3.236
E-Artikel
3.236
E-Ressourcen
Zeitschriftentitel
3.236
ClinicalTrials.gov
Thema
3.236
610
COVID-19
3.236
Study Type: Interventional
1.484
Recruitment Status: Completed
685
Phase: Phase 2
596
Recruitment Status: Recruiting
463
Phase: Phase 3
370
Recruitment Status: Active, not recruiting
335
Recruitment Status: Terminated
300
Medical Condition: COVID-19
273
Phase: Phase 1
224
Recruitment Status: Not yet recruiting
221
Coronavirus Infections
203
Infections
200
Phase: Phase 2, Phase 3
183
Medical Condition: Covid19
179
Phase: Phase 1, Phase 2
167
Phase: Phase 4
163
Recruitment Status: Withdrawn
146
Communicable Diseases
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
488
2024
1.292
2023
1.137
2022
319
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
3.236
Englisch
Haven't found what you're looking for?
Wird geladen...